TickerFacts.

Jazz Pharmaceuticals plc (JAZZ): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

61.44M
As of 2025-12-31
-0.9%
3-year compound annual growth
+1.8%
5-year compound annual growth
63.21M2010-12-31: 39.96M2011-12-31: 42.47M2012-12-31: 58.01M2013-12-31: 57.85M2014-12-31: 60.64M2015-12-31: 61.30M2016-12-31: 59.82M2017-12-31: 58.90M2018-12-31: 57.70M2019-12-31: 56.14M2020-12-31: 56.17M2021-12-31: 61.63M2022-12-31: 63.21M2023-12-31: 62.26M2024-12-31: 60.63M2025-12-31: 61.44M61.44M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3161.44M+1.3%2026-02-24, Balance as of period end
2024-12-3160.63M-2.6%2026-02-24, Balance as of period end
2023-12-3162.26M-1.5%2025-02-26, Balance as of period end
2022-12-3163.21M+2.6%2024-02-28, Balance as of period end
2021-12-3161.63M+9.7%2023-03-01, Balance as of period end
2020-12-3156.17M+0.1%2022-03-01, Balance as of period end
2019-12-3156.14M-2.7%2021-02-23, Balance as of period end
2018-12-3157.70M-2.0%2020-02-25, Balance as of period end
2017-12-3158.90Mn/c2019-02-26, Balance as of period end
2016-12-3159.82M-2.4%2018-02-27, Balance as of period end
2015-12-3161.30M+1.1%2017-02-28, Balance as of period end
2014-12-3160.64M+4.8%2016-02-23, Balance as of period end
2013-12-3157.85M-0.3%2015-02-24, Balance as of period end
2012-12-3158.01M+36.6%2014-02-25, Balance as of period end
2011-12-3142.47M+6.3%2013-02-26, Balance as of period end
2010-12-3139.96Mn/a2012-02-28, Balance as of period end